Zobrazeno 1 - 10
of 122
pro vyhledávání: '"Angela, Takano"'
Autor:
Abu Bakr Azam, Felicia Wee, Juha P. Väyrynen, Willa Wen-You Yim, Yue Zhen Xue, Bok Leong Chua, Jeffrey Chun Tatt Lim, Aditya Chidambaram Somasundaram, Daniel Shao Weng Tan, Angela Takano, Chun Yuen Chow, Li Yan Khor, Tony Kiat Hon Lim, Joe Yeong, Mai Chan Lau, Yiyu Cai
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionDeep learning (DL) models predicting biomarker expression in images of hematoxylin and eosin (H&E)-stained tissues can improve access to multi-marker immunophenotyping, crucial for therapeutic monitoring, biomarker discovery, and personal
Externí odkaz:
https://doaj.org/article/101983bd690749259a72f6f849e2fb52
A Randomized Phase 2 Trial of Nivolumab Versus Nivolumab-Ipilimumab Combination in EGFR-Mutant NSCLC
Autor:
Gillianne G.Y. Lai, MBBS, Jia Chi Yeo, PhD, Amit Jain, MBBS, PhD, Siqin Zhou, MSc, Mengyuan Pang, MSc, Jacob J.S. Alvarez, BSc, Ngak Leng Sim, BCS, Aaron C. Tan, MBBS, FRACP, PhD, Lisda Suteja, BSc, Tze Wei Lim, BSc, Yu Amanda Guo, PhD, Meixin Shen, PhD, Stephanie P.L. Saw, MBBS, Neha Rohatgi, BSc, Joe P.S. Yeong, MBBS, PhD, Angela Takano, MBBS, Kiat Hon Lim, MBBS, Apoorva Gogna, MBBS, Chow Wei Too, MBBS, Kun Da Zhuang, MBBS, Wan Ling Tan, MBBS, Ravindran Kanesvaran, MBBS, Quan Sing Ng, MBBS, Mei Kim Ang, MBBS, Tanujaa Rajasekaran, MBBS, Lanying Wang, MBBS, Chee Keong Toh, MBBS, Wan-Teck Lim, MBBS, Wai Leong Tam, PhD, Sze Huey Tan, PhD, Anders M.J. Skanderup, PhD, Eng-Huat Tan, MBBS, Daniel S.W. Tan, BSc, MBBS, MRCP, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 3, Iss 12, Pp 100416- (2022)
Introduction: Although immune checkpoint inhibitors (ICIs) have dramatically improved outcomes for nononcogene-addicted NSCLC, monotherapy with programmed cell death protein-1 (PD1) inhibition has been associated with low efficacy in the EGFR-mutant
Externí odkaz:
https://doaj.org/article/7d3ef7d52e0641cbadf717aeaf522b4b
Publikováno v:
Respirology Case Reports, Vol 9, Iss 11, Pp n/a-n/a (2021)
Abstract Pulmonary alveolar proteinosis (PAP) can be due to primary autoimmune and secondary causes, including e‐cigarette, or vaping, product use‐associated lung injury. We present a 33‐year‐old male presenting with PAP and a history of vapi
Externí odkaz:
https://doaj.org/article/c5f3fc8ab14d4473b6c90bab53e33890
Autor:
Yannick Simoni, Etienne Becht, Shamin Li, Chiew Yee Loh, Joe Poh Sheng Yeong, Tony Kiat Hon Lim, Angela Takano, Daniel Shao Weng Tan, Evan W Newell
Publikováno v:
Clinical & Translational Immunology, Vol 9, Iss 9, Pp n/a-n/a (2020)
Abstract Objectives Lymphoepithelioma‐like carcinoma (LELC) is an uncommon lung cancer, typically observed in young, non‐smoking Asian populations. LELC is associated with Epstein–Barr virus (EBV) infection of lung tumor cells of epithelial ori
Externí odkaz:
https://doaj.org/article/6ec85d05ca8d42bc82aa8d863e942725
Autor:
Rahul Nahar, Weiwei Zhai, Tong Zhang, Angela Takano, Alexis J. Khng, Yin Yeng Lee, Xingliang Liu, Chong Hee Lim, Tina P. T. Koh, Zaw Win Aung, Tony Kiat Hon Lim, Lavanya Veeravalli, Ju Yuan, Audrey S. M. Teo, Cheryl X. Chan, Huay Mei Poh, Ivan M. L. Chua, Audrey Ann Liew, Dawn Ping Xi Lau, Xue Lin Kwang, Chee Keong Toh, Wan-Teck Lim, Bing Lim, Wai Leong Tam, Eng-Huat Tan, Axel M. Hillmer, Daniel S. W. Tan
Publikováno v:
Nature Communications, Vol 9, Iss 1, Pp 1-11 (2018)
EGFR mutant lung adenocarcinoma (LUAD) exhibit diverse clinical outcomes in response to targeted therapies. Here the authors show that these LUADs involve a complex genomic landscape with high intratumor heterogeneity, providing insights into the evo
Externí odkaz:
https://doaj.org/article/358b10958e814ff3ae9b2917b6e35d5b
Autor:
Chee Kiang Tay, Yang Chong Chua, Angela Takano, Madeline Yen Min Chee, Wan-Teck Lim, Cindy Lim, Mariko Siyue Koh
Publikováno v:
Annals of Thoracic Medicine, Vol 13, Iss 1, Pp 30-35 (2018)
BACKGROUND: Primary pulmonary lymphoepithelioma-like carcinoma (PPLELC) is a rare subtype of nonsmall cell lung cancer (NSCLC) predominantly reported in East Asia. We aimed to evaluate clinical characteristics, diagnosis, treatment, and prognosis of
Externí odkaz:
https://doaj.org/article/9c4010aa7e4d44249b34b529c52d5961
Autor:
Daniel S.W. Tan, Anders J. Skanderup, Axel M. Hillmer, Weiwei Zhai, Eng-Huat Tan, Wai Leong Tam, N. Gopalakrishna Iyer, Wan-Teck Lim, Chee Keong Toh, Lisda Suteja, Ming Jie Lim, Alexis Jiaying Khng, Audrey S.M. Teo, Lanying Wang, Yin Yeng Lee, Bien Soo Tan, Ghee Chee Phua, Devanand Anantham, Tanujaa Rajasekaran, Mei Kim Ang, Quan Sing Ng, Ravindran Kanesvaran, Chow Wei Too, Apoorva Gogna, Wan Ling Tan, Amit Jain, Irfahan Kassam, Marjan Mojtabavi Naeini, Kiat Hon Lim, Joe P.S. Yeong, Zaw Win Aung, Gillianne G.Y. Lai, Neha Rohatgi, Rahul Nahar, Jacob J.S. Alvarez, Angela Takano, Aaron C. Tan, Yvonne H.F. Teng, Khi Pin Chua
Purpose:Despite the established role of EGFR tyrosine kinase inhibitors (TKIs) in EGFR-mutated NSCLC, drug resistance inevitably ensues, with a paucity of treatment options especially in EGFRT790M-negative resistance.Experimental Design:We performed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::227b720107cfdf35e476c0479af15bbd
https://doi.org/10.1158/1078-0432.c.6530516.v1
https://doi.org/10.1158/1078-0432.c.6530516.v1
Autor:
Daniel S.W. Tan, Anders J. Skanderup, Axel M. Hillmer, Weiwei Zhai, Eng-Huat Tan, Wai Leong Tam, N. Gopalakrishna Iyer, Wan-Teck Lim, Chee Keong Toh, Lisda Suteja, Ming Jie Lim, Alexis Jiaying Khng, Audrey S.M. Teo, Lanying Wang, Yin Yeng Lee, Bien Soo Tan, Ghee Chee Phua, Devanand Anantham, Tanujaa Rajasekaran, Mei Kim Ang, Quan Sing Ng, Ravindran Kanesvaran, Chow Wei Too, Apoorva Gogna, Wan Ling Tan, Amit Jain, Irfahan Kassam, Marjan Mojtabavi Naeini, Kiat Hon Lim, Joe P.S. Yeong, Zaw Win Aung, Gillianne G.Y. Lai, Neha Rohatgi, Rahul Nahar, Jacob J.S. Alvarez, Angela Takano, Aaron C. Tan, Yvonne H.F. Teng, Khi Pin Chua
Supplementary Data from Integrative Profiling of T790M-Negative EGFR-Mutated NSCLC Reveals Pervasive Lineage Transition and Therapeutic Opportunities
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::166d4b020fca17d01eb4115553cc3afd
https://doi.org/10.1158/1078-0432.22480715
https://doi.org/10.1158/1078-0432.22480715
Autor:
Matthew C.H. Ng, Alvin Soon Tiong Lim, Yoon Sim Yap, Justina Yick Ching Lam, Tony Kiat Hon Lim, Chee Keong Toh, Su Pin Choo, N. Gopalakrishna Iyer, Mohamad Farid, Amanda O.L. Seet, Chow Wei Too, Rebecca Dent, Elaine Hsuen Lim, Apoorva Gogna, Angela Takano, Daniel S.W. Tan, Wan-Teck Lim, Tira Jing Ying Tan, Eng Huat Tan, Mei Kim Ang, Gek San Tan, Bien Soo Tan, Aaron Tan, Iain Beehuat Tan, Soon Thye Lim, Tse Hui Lim, David Tai, Anders Jacobsen Skanderup
Publikováno v:
JCO Precision Oncology. :859-875
PURPOSE Precision oncology has transformed the management of advanced cancers through implementation of advanced molecular profiling technologies to identify increasingly defined subsets of patients and match them to appropriate therapy. We report ou
Publikováno v:
The Lancet Oncology. 22:e501-e516
Despite the rapidly evolving treatment landscape in advanced non-small-cell lung cancer (NSCLC), developments in neoadjuvant and adjuvant treatments have been nascent by comparison. Establishing overall survival benefit in the early-stage setting has